About this trial
The purpose of this study is to identify functional vascular changes and clinical factors correlated with the occurrence of short- or medium-term hand ischaemia after arteriovenous fistula creation.
Eligibility criteria
Qualifiers
Age ≥ 18 years;
Stage 5 chronic kidney disease, on dialysis or not on dialysis;
Requiring the creation of an arteriovenous fistula;
Membership of a social insurance scheme;
Disqualifiers
Contraindication to the proposed surgery ;
Reduced life expectancy in the opinion of the investigator;
Medical or biological conditions which, in the opinion of the investigator, could influence the interpretation of the results of the study or the safety of the patient;
Patient uncooperative with protocol requirements or unable to attend scheduled visits to the centre;
Trial design
Treatments tested in this trial
- Creation of an arteriovenous fistula
Treatment groups
Sponsors and collaborators
GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead sponsor
Euraxi Pharma
Collaborator